Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer

One of the biggest hurdles for the development of metabolism-targeted therapies is to identify the responsive tumor subsets. However, the metabolic vulnerabilities for most human cancers remain unclear. Establishing the link between metabolic signatures and the oncogenic alterations of receptor tyro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Nan, Bi, Aiwei, Lan, Xiaojing, Xu, Jun, Wang, Xiaomin, Liu, Yingluo, Wang, Ting, Tang, Shuai, Zeng, Hanlin, Chen, Ziqi, Tan, Minjia, Ai, Jing, Xie, Hua, Zhang, Tao, Liu, Dandan, Huang, Ruimin, Song, Yue, Leung, Elaine Lai-Han, Yao, Xiaojun, Ding, Jian, Geng, Meiyu, Lin, Shu-Hai, Huang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586626/
https://www.ncbi.nlm.nih.gov/pubmed/31221965
http://dx.doi.org/10.1038/s41467-019-10427-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586626/
https://www.ncbi.nlm.nih.gov/pubmed/31221965
http://dx.doi.org/10.1038/s41467-019-10427-2

Ejemplares similares